Latest other assets for BBIO: $140M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), BBIO shows a other assets of $140M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, BBIO's other assets is now $140M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether BridgeBio Pharma is outperforming or lagging.
Tracking BBIO's other assets over time shows whether BridgeBio Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $140M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other assets page, Stockcircle has BridgeBio Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $140M) with ownership activity and broader fundamentals.
BridgeBio Pharma's other assets is $140M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.